EMD and/or Bone Substitute for the Treatment of Class II Furcations

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

June 30, 2015

Conditions
Periodontal Disease
Interventions
DRUG

EMD

During flap access surgery, the granulation tissue will be removed and the root surfaces will be carefully instrumented with ultrasonic and hand instruments. The furcation defects in this group will receive the application of enamel matrix derivative (EMD - Emdogain® Straumann, Basel, Switzerland).

DEVICE

βTCP/HA

During flap access surgery, the granulation tissue will be removed and the root surfaces were carefully instrumented with ultrasonic and hand instruments. The furcation will be filled with a bone substitute consisting of beta tricalcium phosphate/hydroxyapatite (βTCP/HA- Bone Ceramic® Straumann, Basel, Switzerland)

PROCEDURE

Flap access surgery

In the furcation sites, during flap access surgery, the granulation tissue will be removed and the root surfaces will be carefully instrumented with ultrasonic and hand instruments.

Trial Locations (1)

13414-903

Piracicaba Dental School, State University of Campinas, Piracicaba

All Listed Sponsors
lead

University of Campinas, Brazil

OTHER

NCT02474498 - EMD and/or Bone Substitute for the Treatment of Class II Furcations | Biotech Hunter | Biotech Hunter